We are enclosing herewith transcript of our Conference Call which was held on Friday, 16th February, 2024 to discuss the Company's Q3 / Nine Months FY24 earnings and business update
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith transcript of our Conference Call which was held on Tuesday, 25th April, 2023 to discuss our acquisition of 33.38% shareholding in Unichem Laboratories Ltd.
